According to a new research report by Global Market Insights Inc, Global Yeast Beta Glucan Market size is estimated to surpass USD 270 Million by 2028 growing at a CAGR of over 8.9%.
The primary application of soluble yeast beta-glucans is the management of diabetic foot ulcers. They contain immunomodulatory properties and can activate white blood cells, which are vital for accelerating the healing of wounds. The primary application of soluble yeast beta-glucans is the management of diabetic foot ulcers. They contain immunomodulatory properties and can activate white blood cells, which are vital for accelerating the healing of wounds.
Additionally, packaged foods & beverages contain beta-glucan derived from yeast. Regular consumption of yeast beta-glucan aids in keeping blood cholesterol levels normal. Furthermore, consuming beverages containing beta-glucan is a simple & delicious way for customers to benefit from cholesterol management.
Yeast beta-glucan is a structural and integral part of animal feed as it serves as an important factor in the growth, body function, and disease resistance among farm animals. Increased investment in agriculture due to increased government efforts to support agribusiness has boosted the market worldwide. Yeast with a purity below 70% is employed in animal feed applications. Saccharomyces cerevisiae is the yeast species that are frequently utilized in the feed industry. The continued growth of the livestock industry and transformation provide important opportunities for agricultural development, increased food security poverty reduction, and improved human nutrition.
The outbreak of COVID-19 epidemic had a bad impact on the global yeast beta glucan market demand. operational disruptions in the supply chain have created a major challenge as demand is reduced due to low purchasing power and willingness to buy. Further, the sales on the premises of supermarkets and grocery stores witness a decline due to the closure of the facilities followed by the closure of the stores, as people continued to follow social media and avoid gathering and going out.
Insoluble form segment is expected to surpass USD 106 Million by 2028 owing to its increasing usage in nutraceuticals & pharmaceutical applications
Yeast beta glucan market from insoluble yeast form is set to witness over 9.6% CAGR from 2022 to 2028. Consumers are increasingly looking for food ingredients with specific health advantages, such as stress alleviation, pain relief, and beauty care benefits like acne treatment and skin improvement. Yeast beta-glucan is an excellent choice for nutritional supplements and as a food ingredient since it acts as a dietary fiber, promotes heart health, and lowers cholesterol.
Browse key industry insights spread across 185 pages with 223 market data tables & 28 figures & charts from the report, ‘’Yeast Beta Glucan Market Size By form (Soluble, Insoluble), By Purity (Below 70%, 70%, 70-85%, Above 85%), By Application (Food & Beverages, Cosmetics, Pharmaceuticals, Animal Feed) Industry Analysis Report, Regional Outlook, Price Trend, Competitive Market Share & Forecast, 2022 – 2028’’ in detail along with the table of contents:
Increasing product penetration of yeast beta-glucan extracts in the cosmetics industry and a rapid shift toward natural ingredients are likely to trigger market share
Yeast beta glucan market from 70%-85% purity is set to witness over 9.2% CAGR from 2022 to 2028. Yeast beta-glucans are used in the personal care industry to promote hydration and comfort while enhancing skin firmness and elasticity. it shields skin cells from UV rays and promotes the production of collagen and fibroblasts. Moreover, most of this purity segment is also consumed by pharmaceutical and cosmetic manufacturers for the production of skin-related products. The market share of yeast will increase owing to the high concentration of antioxidant beta-glucan agents. Yeast is widely used in manufacturing a diverse range of natural cosmetics from toners, creams, and sunscreens.
The consumption of health and wellness foods has increased as consumers become more aware of the production procedures, health claims, and labels on food and beverage goods thus it will fuel market demand
Pharmaceutical industry will increase owing to its use in medicines such as common cold, influenza, season allergies, and respiratory tract infections. The market share of pharmaceutical yeast will increase as it is a source of vitamins, beta-glucan, and protein. Wellness food consumption is rising as a result of increased consumer worries about environmental issues, the negative effects of food additives, and the health dangers of obesity. The health hazards of obesity, such as insulin resistance, stroke, coronary artery disease, hypertension, type 2 diabetes, and metabolic syndrome, are decreased by beta-glucan dietary fiber.
The rising demand for nutraceutical applications in the Asia Pacific will propel business demand in the region
Asia Pacific yeast beta glucan market is set to cross USD 53 million by 2028. Veterinarians adopt high-protein foods to boost the immune system and overall health, which is expected to result in the need for dietary supplements. A polysaccharide called yeast beta glucan interacts with immune cells to enhance the body's immunological responses. Due to its multiple health advantages, including its capacity to lower cholesterol, aid in the reduction of cholesterol, and enhance gut health, yeast beta-glucan has been regarded as a desirable dietary element. Further, yeast beta glucan should be fueled by rising consumer awareness of the nutritional benefits of the crop and rising farmer awareness of the crop's ability to generate cash through trade.
Major industry players operating in the global yeast beta glucan market include Kerry Group, Angel Yeast Co. Ltd, Ohly, Specialty Biotech Co., Ltd, Mitushi Biopharma, Hiyeast, Zhuhai, TXY Biotech Holding Co. Ltd, Aria Ingredients, & Sinofi. The key strategies observed among the industry participants include new acquisitions, new product development, and expansion.